top of page

Revolutionizing Radiopharmaceutical Development through the Innovative Peptide Discovery Platform CUS™

Founded in 2017, C-Biomex Co., Ltd is a pioneering bio-venture focused on advancing novel theranostics using

its exclusive peptide discovery platform technology.

About Us


Our innovative discovery platform, CUS™, facilitates the identification of peptides with remarkable stability and selectivity through a three-differentiated approach: (1) Crafting a high-purity library using an optimized process,

(2) Employing a novel screening procedure that minimizes background interactions, and

(3) Achieving direct sequencing utilizing our proprietary analyzing algorithm.

Our Technology

Proprietary Peptide Discovery Platform (CUS™)


High professionalism and global level competency

bottom of page